IDRA - Idera Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 2.34
52-Week Change 3-73.32%
S&P500 52-Week Change 318.19%
52 Week High 37.0000
52 Week Low 31.6700
50-Day Moving Average 32.2735
200-Day Moving Average 32.5379

Share Statistics

Avg Vol (3 month) 3144.38k
Avg Vol (10 day) 3224.63k
Shares Outstanding 528.87M
Float 20.28M
% Held by Insiders 120.41%
% Held by Institutions 145.77%
Shares Short (Nov 15, 2019) 4608.21k
Short Ratio (Nov 15, 2019) 46.99
Short % of Float (Nov 15, 2019) 42.65%
Short % of Shares Outstanding (Nov 15, 2019) 42.11%
Shares Short (prior month Oct 15, 2019) 4507.85k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 28/1
Last Split Date 3Jul 30, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-3,005.75%

Management Effectiveness

Return on Assets (ttm)-44.50%
Return on Equity (ttm)-80.77%

Income Statement

Revenue (ttm)1.55M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-25.37M
EBITDA -46.37M
Net Income Avi to Common (ttm)-45.43M
Diluted EPS (ttm)-1.6200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)41.59M
Total Cash Per Share (mrq)1.44
Total Debt (mrq)138k
Total Debt/Equity (mrq)0.37
Current Ratio (mrq)5.80
Book Value Per Share (mrq)1.30

Cash Flow Statement

Operating Cash Flow (ttm)-45.64M
Levered Free Cash Flow (ttm)-28.39M